Foreign investment and regulatory gaps in Italy's emerging "cannabis light" market

Foreign investment and regulatory gaps in Italy's emerging "cannabis light" market The passage outlines how Canadian firms have taken stakes in Italian hemp/CBD companies and describes lax enforcement of health‑ministry approvals. It hints at possible regulatory arbitrage and undisclosed financial flows, but provides no concrete names of high‑level officials, transaction amounts, or evidence of wrongdoing, limiting its immediate investigative value. Key insights: Italian law permits up to 0.6% THC, creating a niche for "cannabis light" products marketed as non‑consumable collector items.; Foreign firms (Wayland, LGC Capital, Canopy, CROP) have acquired sizable stakes (30‑47%) in Italian CBD businesses between 2018‑2019.; Health Ministry product approvals are rarely enforced, suggesting regulatory loopholes.